Practical utility of specific red cell adherence test in bladder cancer

Area of Science:

• Oncology
• Immunology
• Urology

Background:

• Bladder cancer recurrence and progression remain significant clinical challenges.
• Accurate prediction of tumor behavior is crucial for effective patient management.
• Specific red cell adherence (SRCA) tests for ABO(H) blood group antigens have shown potential as prognostic markers.

Purpose of the Study:

• To investigate the correlation between SRCA test results and the biologic potential of bladder cancer.
• To evaluate the utility of SRCA tests in predicting superficial tumor recurrences and the development of invasive cancer.
• To determine the clinical applicability of SRCA tests in guiding treatment decisions.

Main Methods:

• Correlation analysis between SRCA test results (ABO(H) blood group antigens) and bladder cancer outcomes.
• Evaluation of SRCA test performance in predicting superficial recurrences and invasive progression.
• Assessment of SRCA test utility in patient selection for specific therapies like early cystectomy or conservative management.

Main Results:

• A highly significant correlation exists between SRCA test results and bladder cancer's biologic potential.
• SRCA tests have limited practical value for predicting superficial recurrences due to high false-negative rates.
• SRCA tests are not definitive for selecting patients for early cystectomy, as invasive cancer does not develop in all SRCA-negative cases.
• SRCA tests may identify high-grade, antigen-positive tumors suitable for conservative therapy, as invasive progression is less than 10% in these cases.

Conclusions:

• SRCA tests show a significant correlation with bladder cancer prognosis, particularly for invasive potential.
• Caution is advised when interpreting SRCA tests in patients with prior radiation or thiotepa treatment, or in those with type O blood.
• SRCA testing may aid in selecting specific high-grade bladder tumors for conservative treatment approaches.